TNP-470

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), M.D. Anderson Cancer Center

Conditions

HIV InfectionsPancreatic NeoplasmsSarcoma, Kaposi

Phase 1

A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

CompletedNCT00000763

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Sarcoma, Kaposi

End: 1997-02-28Target: 42Updated: 2021-11-03

Phase 2

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

TerminatedNCT00038701

M.D. Anderson Cancer CenterPancreatic Neoplasms

Start: 1999-08-31End: 2004-05-11Updated: 2018-11-01